Pharma as an industry plays a vital role in healthcare and human lives. From a wider perspective, the Indian pharmaceutical sector supplies over 50 percent of global demand for various vaccines, and prides an important position in the global market. With this immense growth, the country has become home for companies that have potential to steer the industry ahead to a higher level. Among plentiful such pharma products manufacturing brands, RADIANT PARENTERALS comes as a company that is committed to drive quality healthcare.

Ideated over three decades ago, it launched the first unit in 1986 in Gujarat and evolved as one of the fastest-growing pharmaceutical companies in India. As one of the top companies in the niche, RADIANT manufactures Small Volume Liquid Parenterals (general) having a capacity of 1.25 crore ampoules per month and oral-liquids having a capacity of 25.00 lakh bottles per month, which have found way very well into the practitioner's prescription and in people's lives. RADIANT's world-class manufacturing plants are based in Waghodia G.I.D.C in Gujarat, which is WHO-GMP & ISO 9001-2015 certified company. It is in the process of establishing an R&D facility to spearhead the discovery of New Chemical Entities (NCE).

"We at RADIANT take pride to fulfill the instinct of success by taking an oath to serve and satisfy the needs of our customers through

innovative medicines from both conventional and alternative healthcare systems. We are committed to providing quality medication at affordable prices to the patients to help bring down healthcare costs, whilst we continue to enhance the momentum of our products and also accelerate our drug discovery program through collaborations and alliances globally," is what the company website claims.

The Flagship Products
Under WHO GMP guidelines and compliance, the company has manufactured products called REKFA, a unique composition of omega-3 & omega-6 Essential fatty acid, REKFA (Capsules, Cream, and Drops), REKSEAL (0.25ml, 0.50ml, and 1.00ml) ­ a Tissue Adhesive, and PILET ­ an Ayurvedic products for Piles that cures up to second degree piles in five days. It also manufactures psychotropic products such as Pentazocine injection, Buprenorphine injection and Tramadol injection. The portfolio includes certain products like Cerebrolysin injection, Hydralazine HCL injection, and many others that are exported to Kenya, Bangladesh, Sri Lanka, Nepal, Vietnam, Malaysia, Zambia, Myanmar, and others. Following ethical sales, all are priced at an affordable rate to not tax a common man on health. It has in-house laboratory equipped with high-end analysis machines such as TOC and HPLC infrared to ensure the quality of the product. Its laboratory is approved by GLP certification.

We take pride to fulfill the instinct of success by taking an oath to serve and satisfy the needs of our customers through innovative medicines from both conventional and alternative healthcare systems

Bright Future Ahead
As a successful brand, RADIANT aspires to be in the top 100 firms and invests in the growth of people and business, marching towards the new horizon of global leadership. After the introduction of antihypertensive and diabetic product range, RADIANT has plans to come-out with anti-cancer, and drugs for the treatment of HIV and other viral infections.

RADIANT wishes to spread its wings all over India in the domestic market and enter into the new foreign markets of eastern Asia, Europe Gulf countries, and African continent. The company has already set-up a plant in Baddi and has plans to go for US-FDA in the coming years. It is working towards R&D Department with all kinds of technological advancement to have a chain of company's retail medical outlets in all the metros of India, which will remain open 24 hours a day.